01 / FIBRE CONTENT
Nutrition Targets
Determine analytical fibre contribution, serving size and eligibility for local fibre-related labelling.
INGREDIENT
Olifructine™
INGREDIENT FAMILY
Branched Fructans
DEVELOPMENT FOCUS
Fibre & Mouthfeel
THE FORMULATION CHALLENGE
Nutritional product development increasingly explores food formats that combine dietary fibre, protein and satisfying sensory characteristics.
Reformulating foods and beverages to modify their nutritional composition can affect body, mouthfeel, sweetness perception and flavour balance. These changes may be especially challenging in protein-rich formulations.
Olifructine™ Organic Agave Fructans provide a soluble dietary fibre ingredient for manufacturers evaluating these formulation needs. Product-specific testing remains essential.
NUTRITIONAL PRODUCT DEVELOPMENT
01 / FIBRE
Incorporate soluble agave fructans when developing products with defined dietary fibre targets.
02 / TEXTURE
Evaluate mouthfeel, body, creaminess and ingredient interactions in reformulated foods and beverages.
03 / INNOVATION
Explore the relationship between fermentable dietary fibres, gut microbiota and emerging areas of metabolic nutrition research.
THE SCIENCE / MOLECULAR ARCHITECTURE
The official Olifructine™ brief describes naturally branched agave fructans with a broad degree-of-polymerisation range, approximately DP 2–50+. This molecular architecture informs ongoing research into their fermentation characteristics and technological applications.
BRANCHED ARCHITECTURE
Unlike the predominantly linear structure associated with conventional chicory inulin, agave fructans include branching patterns relevant to their physicochemical properties.
BRIEF REFERENCE
DP 2–50+
Approximate described range
FERMENTATION RESEARCH
The brief proposes a gradual fermentation profile for branched agave fructans and describes the potential generation of short-chain fatty acids (SCFA) along the colon.
The extent, timing and physiological significance of these processes depend on ingredient composition, experimental conditions and the individual host.
EMERGING SCIENCE / GUT-METABOLIC SIGNALLING
The supplied brief connects agave fructan fermentation with microbial SCFA production and research into intestinal signalling pathways. GLP-1 is one hormone investigated in this wider field of gut-metabolic science. This conceptual pathway should not be interpreted as a demonstrated clinical outcome for Olifructine™.
STAGE 01
Branched soluble fibre enters the digestive system.
STAGE 02
Microbial utilisation is evaluated as part of the proposed mechanism.
STAGE 03
Fermentation metabolites are studied for their biological relevance.
RESEARCH AREA
Potential relationships with L-cell activity, GLP-1 and satiety are topics for scientific investigation.
Conceptual research pathway only. No demonstrated treatment effect, weight-loss outcome or clinically meaningful GLP-1 response is claimed for Olifructine™.
R&D CONSIDERATIONS
The official brief discusses fibre content, microbiota research, fermentation and digestive tolerance. The following parameters offer a framework for professional evaluation; they are not universal recommended doses or substantiated consumer claims.
01 / FIBRE CONTENT
Determine analytical fibre contribution, serving size and eligibility for local fibre-related labelling.
02 / MICROBIOTA
Assess microbial utilisation and relevant populations in scientifically appropriate studies.
03 / TOLERANCE
Evaluate ingredient tolerance and gastrointestinal responses using suitable protocols and target populations.
FOOD & BEVERAGE INNOVATION
The official brief identifies seven food and beverage categories where Olifructine™ may be evaluated for fibre enrichment, texture and sensory formulation objectives.
Texture and firmness evaluation.
Softness and mouthfeel considerations.
Body, solubility and sensory balance.
Creaminess and texture development.
Body, texture and fibre incorporation.
Spreadability and consistency.
Texture and flavour-profile evaluation.
PRACTICAL FORMULATION
Developing fibre-enriched foods and beverages is not only a nutritional challenge. Product acceptance also depends on texture, consistency, appearance and taste.
Olifructine™ can be assessed within integrated formulations where protein systems, sweeteners and dietary fibre must perform together.
EVALUATION CHECKLIST
SCIENTIFIC DOCUMENTATION
The official Olifructine™ GLP-1 formulation brief presents a conceptual diagram of branched molecular architecture and a comparative fermentation-kinetics illustration. These visuals will be incorporated after uploading the approved artwork to Shopify and reviewing their scientific context and references.
SCIENTIFIC VISUAL 01
Official illustration of agave fructan branching and the proposed gut fermentation pathway.
SCIENTIFIC VISUAL 02
Official conceptual comparison of linear chicory inulin and branched agave fructans across gut regions.
NUTRIAGAVES GROUP / R&D COLLABORATION
Connect with NutriAgaves Group to explore ingredient specifications, formulation support and technical documentation for nutrient-focused food and beverage development.
CONTACT OUR R&D TEAM →INGREDIENT RESOURCES
Learn more about our organic agave fructans and access the NutriAgaves Group ingredient catalogue.
OLIFRUCTINE™ ↗ CATALOGUE ↗Information intended exclusively for professional food and beverage research and formulation audiences. GLP-1-aligned product development is a nutritional formulation concept and does not indicate a pharmacological effect. Olifructine™ is not a GLP-1 receptor agonist or a medicine. No claims of weight loss, appetite suppression, increased GLP-1 secretion or therapeutic benefit are made for the ingredient. Fibre claims, prebiotic activity, digestive tolerance, fermentation patterns and health-related statements require suitable evidence and applicable regulatory approval or review.